One of the benefits of the phase-in is that it will allow the federal government to work with the provinces to see what the delta will be once the extension comes into play as part of a multi-year health and social transfer. Our government has increased that. We've not cut it like the previous government did.
You mentioned the 12,000 jobs in the generic industry in Canada. I know some of the excellence in southern Ontario with respect to the industry, and I applaud it. You talked about research and manufacturing. How many of those jobs would be on the research side of the industry?